Principal Financial Group Inc Fortress Biotech, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.8 - $1.5 $10,756 - $20,169	-13,446 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.24 - $2.75 $1,171 - $2,598	945 Added 7.56%	13,446 $18,000
Q4 2021 Feb 09, 2022	SELL	$2.42 - $3.65 $6,485 - $9,782	-2,680 Reduced 17.65%	12,501 $31,000
Q3 2021 Nov 09, 2021	BUY	$2.82 - $3.7 $11,170 - $14,655	3,961 Added 35.3%	15,181 $49,000
Q2 2021 Aug 10, 2021	SELL	$3.5 - $5.48 $8,389 - $13,135	-2,397 Reduced 17.6%	11,220 $40,000
Q1 2021 May 10, 2021	SELL	$3.16 - $4.89 $6,771 - $10,479	-2,143 Reduced 13.6%	13,617 $48,000
Q4 2020 Feb 08, 2021	BUY	$2.2 - $4.45 $34,672 - $70,132	15,760 New	15,760 $50,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $181M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.